Sarcoidosis remains an enigma in modern medicine. Its hallmark is the formation of noncaseating granulomas, primarily in the lungs, yet the disease extends ...

The annual incidence of cardiac sarcoidosis is low, but increased awareness of this inflammatory condition has led to earlier ...

On Saturday, April 5, The Bernie Mac Foundation will hold its eighth annual Purple Carpet Fundraiser at the Orland Chateau in ...

Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and ...

Dr. Jad Kebbe, a pulmonologist at the University of Oklahoma Health Sciences Center, discusses the risks of inhaling wildfire smoke, including short- and long-term lung damage, and offers tips for ...

Listen to a short summary Read by Sharon R. Your browser does not support the audio element.Bridgette Ann Greer loved ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where aTyr ...

Hiring Dalia Rayes as head of commercial for the global efzofitimod franchise slots another piece of the puzzle into place.

SAN DIEGO, March 26, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage ...

Key findings • Sarcoidosis patients are prone to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, increased severity, morbidity and greater mortality of coronavirus disease 2019 ...

Chronic bronchitis Cystic fibrosis Emphysema Empyema Epilepsy Bronchiectasis Asthma Asbestosis Extrinsic allergic alveolitis ...

XTMAB-16 is an anti-TNFa monoclonal antibody currently under investigation. Based on its ability to block TNFa, XTMAB-16 may disrupt an inflammatory pathway and help slow granuloma formation. XTMAB16 ...